B-cell-depleting induction therapy and acute cellular rejection

N Engl J Med. 2009 Jun 18;360(25):2683-5. doi: 10.1056/NEJMc0808481.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • B-Lymphocytes*
  • Cytokines / blood
  • Daclizumab
  • Graft Rejection / immunology*
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Kaplan-Meier Estimate
  • Kidney Transplantation / immunology*
  • Lymphocyte Count
  • Lymphocyte Depletion*
  • Rituximab
  • Transplantation Conditioning
  • Transplantation Immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Cytokines
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Rituximab
  • Daclizumab